Your browser doesn't support javascript.
loading
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.
Kao, Steven C; Cheng, Yuen Yee; Williams, Marissa; Kirschner, Michaela B; Madore, Jason; Lum, Trina; Sarun, Kadir H; Linton, Anthony; McCaughan, Brian; Klebe, Sonja; van Zandwijk, Nico; Scolyer, Richard A; Boyer, Michael J; Cooper, Wendy A; Reid, Glen.
Afiliação
  • Kao SC; Asbestos Diseases Research Institute, Sydney, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Cheng YY; Asbestos Diseases Research Institute, Sydney, Australia.
  • Williams M; Asbestos Diseases Research Institute, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Kirschner MB; Asbestos Diseases Research Institute, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Madore J; Sydney Medical School, The University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia.
  • Lum T; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Sarun KH; Asbestos Diseases Research Institute, Sydney, Australia.
  • Linton A; Asbestos Diseases Research Institute, Sydney, Australia; Department of Medical Oncology, Concord Cancer Centre, Sydney, Australia.
  • McCaughan B; Sydney Medical School, The University of Sydney, Sydney, Australia; Sydney Cardiothoracic Surgeons, RPAH Medical Centre, Sydney, Australia.
  • Klebe S; Department of Anatomical Pathology, Flinders University and SA Pathology at Flinders Medical Centre, Adelaide Australia.
  • van Zandwijk N; Asbestos Diseases Research Institute, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Scolyer RA; Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Department of Medical Oncology, Concord Cancer Centre, Sydney, Australia.
  • Boyer MJ; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Cooper WA; Sydney Medical School, The University of Sydney, Sydney, Australia; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia; School of Medicine, Western Sydney University, Sydney, Australia.
  • Reid G; Asbestos Diseases Research Institute, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. Electronic address: glen.reid@sydney.edu.au.
J Thorac Oncol ; 12(9): 1421-1433, 2017 09.
Article em En | MEDLINE | ID: mdl-28629895
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / MicroRNAs / Antígeno B7-H1 / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Thorac Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / MicroRNAs / Antígeno B7-H1 / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: J Thorac Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália